FNAM (Evolutionary Genomics) Forward Dividend Yield %: 0.00% (As of Jul. 13, 2026)


FNAM Evolutionary Genomics Inc FNAM
31 GF Score
Price $0.00
View Full Analysis

What is Evolutionary Genomics Forward Dividend Yield %?

Evolutionary Genomics FNAM 31 Forward Dividend Yield % is 0.00% as of Jul. 13, 2026. GuruFocus rates FNAM with a GF Score™ of 31/100.

As of today (2026-07-13), the Forward Annual Dividend Yield of Evolutionary Genomics is 0.00%.

As of today (2026-07-13), the Trailing Annual Dividend Yield of Evolutionary Genomics is 0.00%.

FNAM's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.275
* Ranked among companies with meaningful Forward Dividend Yield % only.

Evolutionary Genomics's Dividends per Share for the three months ended in Dec. 2022 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Evolutionary Genomics  (OTCPK:FNAM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Evolutionary Genomics Forward Dividend Yield % Related Terms

FNAM vs BXRX, GNCA, XSNX: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Evolutionary Genomics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolutionary Genomics Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Evolutionary Genomics's Forward Dividend Yield % falls into.


FNAM
31GF Score
Evolutionary Genomics Inc FNAM
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolutionary Genomics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Evolutionary Genomics (FNAM) has a Forward Dividend Yield % of 0.00% as of Jul. 13, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Evolutionary Genomics and its competitors.
Is Evolutionary Genomics' Forward Dividend Yield % too high?
Evolutionary Genomics' current Forward Dividend Yield % is 0.00%. Overall, Evolutionary Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Evolutionary Genomics' Forward Dividend Yield % compare to BXRX and GNCA?
Evolutionary Genomics' Forward Dividend Yield % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Forward Dividend Yield % is 1.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.28, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Evolutionary Genomics and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolutionary Genomics's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolutionary Genomics stock overvalued right now?
Evolutionary Genomics (FNAM) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Evolutionary Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Evolutionary Genomics (FNAM), the current Forward Dividend Yield % is 0.00% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evolutionary Genomics Business Description

Address 4220 Morning Star Drive, Castle Rock, CO, USA, 80108
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
31GF Score

Get the complete analysis for FNAM

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price